Waterloo Capital L.P. Sells 94 Shares of The Clorox Company (NYSE:CLX)

Waterloo Capital L.P. lessened its stake in shares of The Clorox Company (NYSE:CLX) by 2.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 3,317 shares of the company’s stock after selling 94 shares during the period. Waterloo Capital L.P.’s holdings in Clorox were worth $539,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of CLX. Norges Bank bought a new position in Clorox during the 4th quarter valued at about $259,041,000. ExodusPoint Capital Management LP increased its holdings in shares of Clorox by 187.9% during the fourth quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock worth $113,508,000 after buying an additional 456,114 shares in the last quarter. Amundi raised its stake in shares of Clorox by 42.6% in the fourth quarter. Amundi now owns 1,032,283 shares of the company’s stock valued at $165,816,000 after acquiring an additional 308,234 shares during the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of Clorox by 302.0% in the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after acquiring an additional 265,455 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in Clorox during the 4th quarter worth approximately $37,935,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of CLX opened at $143.76 on Monday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm has a market capitalization of $17.71 billion, a PE ratio of 39.28, a P/E/G ratio of 2.62 and a beta of 0.45. The stock has a 50 day simple moving average of $150.06 and a 200 day simple moving average of $158.36. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm earned $2.16 EPS. Sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.39%. Clorox’s dividend payout ratio (DPR) is currently 133.33%.

Analysts Set New Price Targets

CLX has been the topic of a number of recent analyst reports. Wells Fargo & Company reduced their price objective on Clorox from $161.00 to $155.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 2nd. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. Barclays lowered their price objective on shares of Clorox from $140.00 to $139.00 and set an “underweight” rating for the company in a research report on Thursday, March 27th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, DA Davidson lowered their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $159.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.